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DEVELOPMENTS IN DELAYED-TYPE HYPERSENSITIVITIES: 1950-1975 
MERRILL W. CHASE, PH.D. 
Laboratory of Immunology and Hypersensitivity, The Rockefeller University, New York, New York, U. S. A. 
Significant developments during the last 25 years are discussed and interpreted. The 
following areas of delayed hypersensitivity are included: the mode of active sensitization to 
simple allergenic chemicals; evidence for anamnestic responses; cell types and cell-cell 
interactions via lymphokines; function of skin and lymphatics, and the role of the carrier in 
initial sensitization to allergenic chemicals; acquired tolerance; transfer factor. Some prog-
nostications for the future are attempted. 
BACKGROUND 
Without benefit of government support, the 
years before 1950 witnessed an emergence of signif-
icant knowledge which would influence the subse-
quent quarter-century. By 1950, quantitative im-
munochemistry had been established even though 
the various classes of immunoglobulins were still 
unknown. Pneumococcal "types" had been trans-
formed, that is , the synthesis of new capsular 
polysaccharides had been induced by the addition 
of pneumococcal extracts , and with this achieve-
ment came an early but limited recognition of the 
complexity and role of DNA in biology. The 
complement system was lusty but not yet out of 
diapers. 
Between 1935 and 1950, significant facts about 
contact hypersensitivity had been disclosed by 
means of simple chemicals. The results of Land-
steiner and Jacobs [1] in their study of the sensitiz-
ing capacity of nitro-substituted and chloro-sub-
stituted benzenes in guinea pigs had shown that 
this class of chemicals sensitizes only when the 
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Abbreviations: 
B-: bone marrow-derived 
CBH: cutaneous basophil hypersensitivity 
CF A: complete Freund's adjuvant 
CMI: cell-mediated immunity 
D-H: delayed-type hypersensitivity 
DNCB: dinitrochlorobenzene 
DNFB : dinitrofluorobenzene 
DNP: dinitrophenylated 
DMSO: dimethylsulfoxide 
EAC: erythrocyte-antibc dy-complement com-
plex 
IFA: incomplete Freund's .ldjuvant 
MIF: macrophage inhibition factor 
MLC: mixed lymphocyte culture 
NDMA: p -nitrosodimethylaniline 
PC1: picryl chloride 
PMN: polymorphonuclear leukocyte 
T- : thymus-derived 
TF: transfer factor. 
particular compound possesses a labile substituent 
which allows hapten-protein complexes to form, 
and that carrier protein is represented by the host's 
own structural elements. These results were later 
embellished by Eisen, Orris, and Belman [2], who 
found that the ability not only to sensitize but also 
to elicit reactions requires compounds with labile 
substituents. Delayed-type hypersensitivities 
(D-H) had been transferred to normal , outbred, 
recipient guinea pigs by means of white cells from 
sensitized animals, both for allergic contact der-
matitis and for cutaneous hypersensitivity to tu-
berculin [3,4 J. One could then appreciate how 
transfers of unclarified blister fluids , secured just 
below the sites of positive contact reactions on 
human beings, had been irregularly reported to 
transfer contact dermatitis in the Urbach-Konig-
stein technique [5 J. 
Another subject had been introduced, seemingly 
of no interest to dermatologists or allergists since 
the experiments were being done with guinea pigs. 
When normal guinea pigs were fed sensitizing 
chemicals in triglyceride oil before sensitizing 
courses with the same chemical had been under-
taken , a state of specific unresponsiveness to the 
acquisition of D-H could be established (see The 
Unresponsive State below). 
Again, Jules Freund [6] had confirmed the 
findings of Coulaud [7] and Saenz [8,9], namely, 
that pronounced sensitivity to tuberculin arises 
when heat-killed virulent mycobacteria are sus-
pended in hydrocarbon or paraffin oil before in-
jection. Shortly afterwards, Freund made his 
unique contribution, an expansion of earlier exper-
iments by Dienes and Schoenheit [10], i.e., the 
incorporation of water-soluble or water-suspended 
material dispersed within the paraffin oil-myco-
bacterial continuous phase by means of special 
water-in-oil (W /0) emulsifiers (Aquaphor, Protegin-
X, Falba, Arlacel A). Later, Freund with McDer-
mott (11] showed that such dispersed antigens give 
rise to D-H and to an extraordinary synthesis of 
precipitating antibody by guinea pigs, and Land-
steiner and Chase (review in [12]) induced contact 
sensitivity to picryl chloride in guinea pigs by se-
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quential intraperitoneal injections of dead tubercle 
bacilli in paraffin oil and of aqueous suspensions of 
the picrylated ghosts of guinea-pig erythrocytes . 
If taken in strict chronologie order, the sweep of 
events over 25 years in any given discipline would 
be a jumble because of the various facets of 
delayed hypersensitivity. Taken together, they 
require a separate volume such as Turk's [13]. We 
think at once of primary homograft rejection, 
poison ivy, and other contactants, hypersensitivity 
in mycobacterial and fungal diseases, rare reac-
tions to medicaments, and the story of transfer 
factor. Obviously compartmentalization is needed 
even for this superficial review. Furthermore, stud-
ies on experimental animals, chiefly the guinea 
pig, will be cited whether or not parallel findings 
exist or have been sought for in man. 
ACTIVE SENSITIZATION 
Methods of Sensitizing 
Various procedures have been developed to in-
duce allergic contact-type sensitivity to chemical 
agents (Tab. I) . Classically, for both man and 
guinea pigs, the skin route (s ingle or repeated 
application on or into the skin) has played a 
dominant role. The value of pre-irritation of the 
TABLE 1. Sensitization of guinea pigs to simple chemicals 
1. percutaneous absorption 
Salves (Vaseline , lanolin , Orabase) and oils 
Closed patches (Magnusson) 
Local irritation as an assist: 
Self-irritant concentrations, e.g ., 2% DNCB In 
ethanol 
Incorporation of irritant, as organic peroxides 
Applications of dilute cantharidin (Landsteiner) 
Freon 12 on human subjects (Kligman) 
Dry ice burns (Maguire) 
Skin masceration by 5% SDA (Magnusson and 
Kligman) 
Dimethylsulfoxide (DMSO ) solutions 
2. Intradermal injections of microgram amounts 
Typical solvents: 4% alcohol in saline , corn oil , 
paraffin oil 
3. Use of mycobacteria-liquid hydrocarbon suspensions 
W /0 emulsion with emulsifier ("CFA") 
Simple chemical in aqueous phase 
Simple chemical in hydrocarbon phase 
Hapten-carrier complexes in aqueous phase 
Mycobacteria in paraffin oil i.d ., followed at 24 hr 
by i.d. allergen into sites -(Split-adjuvant tech-
nique of Maguire ) 
Mycobacteria in paraffin oil i.d. , followed by dry ice 
application, salve, and occlusive dressing (Ma-
guire) 
4. "Combination" -Hapten-carrier complex in CFA, 
then contact tests with hapten on days 10 and 17 
5. Intradermal injections of hapten-epidermal tissue 
complexes (Chase and Kawata) 
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skin is firmly established for both man and animal. 
Pre-irritation techniques have been used vigor-
ously to better exploit the use of the guinea pig for 
prospective studies of materials intended for 
human use [14-16]. 
The other principal technique makes use of 
"complete" Freund's adjuvant (CFA) in which 
W /0 emulsions are injected, the mycobacterial 
cells being in the continuous phase of paraffin oil. 
This assist works on a different principle since 
attacking cells carry minute droplets of emulsion 
throughout the body with slow release of the 
contained aqueous droplets and well-nigh perma-
nent deposition of mycobacteria and oil in the 
tissues [17]. As stated above, hypersensitivity to 
tuberculin is established simultaneously. Besides 
the depot role of CF A, there is evidence for a direct 
and early stimulation of lymphoid cells by myco-
bacteria [18]. 
Sensitization to microbial agents is usually ef-
fected, as in man, by invasion of tissues with living 
organisms or by supplying these killed, in antigenic 
dosage. In particular instances, a temporary state 
of delayed hypersensitivity has been facilitated by 
using "incomplete" Freund's adjuvant (IFA, that 
is , paraffin oil-plus-Arlacel A, but without myco-
bacteria) as a depot for antigen The term "Jones-
Mote" is often borrowed by immunologists to 
describe this sensitivity. 
Skin grafts placed upon outbred or histoincom-
patible animals represent another mode of devel-
oping D-H and of securing lymphocytes which 
upon transfer will induce speedy rejection of an 
established homograft . The parallelism with aller-
gic contact dermatitis was clearly established in 
experiments on guinea pigs , in which tests for D-H 
can be made readily. Thus, intradermal injection 
had shown that animals which had rejected homo-
grafts had become sensitized to living cells or 
extracts of tissues of the donor animal; visually 
and histologically the D-H responses were typical. 
This test is termed the direct hypersensitivity 
reaction [19 ,20 ]. The reverse procedure, i.e. , injec-
ting the white cells of the rejecting animal into the 
skin of the original homograft donor, is naturally 
positive also; basically, it is a graft-versus-host 
reaction [21]. 
Anamnestic Responses in Delayed 
Hypersensitivity 
"Boosting" the titer of immunoglobulins by 
reinjecting antigen is the classical type of 
anamnestic response, yet boosting also occurs, 
although seldom recognized, in D-H. In the sim-
plest case, guinea pigs receiving an intradermal 
injection of dinitrochlorobenzene (DNCB) but not 
scoring highly in the subsequent contact test are 
often found to display much more intense reactions 
in a second contact test. Investigation showed that 
the first test is a prerequisite and that it should be 
made within 3 weeks of the sensitizing injection. 
After the second test is appropriately made within 
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2 to 3 weeks, contact reactivity of long duration 
sets in and often remains at high level for over a 
year. 
Pronounced examples of ascending sensitivity 
induced by subsequent contact testing are encoun-
tered when hapten-homologous erythrocyte stro-
mata are injected in CFA [12,22]. The animal may 
finally react to contact with as little as 0.0025 % 
solution in triglyceride oil. In the split-adjuvant 
technique introduced by Maguire and Chase [23], 
picric acid is injected intradermally and, later, 2.5 
f.Lg of mycobacteria in 0.05 ml of paraffin oil are 
injected into the same sites. The stage is set for a 
marked increase in contact sensitivity when 2 or 3 
spaced contact tests are made with picric acid 
[24,25]. Indeed, peritoneal exudate cells obtained 
early and late in the sensitizing routine differed in 
transfer capacity: the early cells transferred the 
indolent, slow responses of their donors; and the 
late cells, a sharply ascending, intense reactivity. 
Transferring fewer of the late cells caused decreas-
ing reactions, but of a constant type. Since dilution 
did not imitate the response to early cells, there 
had been a qualitative, not a quantitative, altera-
tion in the lymphocytes during the anamnestic 
responses [25]. 
Theories of the mechanism must take into ac-
count a possible switch in hapten-carrier as one 
element. Initial intradermal injections might find 
a dermal sensitizing carrier and contact-testing 
might utilize an epidermal carrier (see The Unre-
sponsive State). But the stepwise boosts by the 
several contact tests remain true anamnestic re-
sponses. 
Histology of D-H Reactions 
Sequential biopsies in animals after skin tests 
show lymphocytes and other cells emerging from 
the lumen of blood vessels and migrating upwards 
towards and beyond the dermal-epidermal junc-
tion to the site of the test application; many 
clusters remain around vessels in the dermis. 
Spongiosis and edema are observed in the devel-
oped reaction. Typical examples are given by 
Macher and by Fisher for DNCB contact tests 
[26,27]. Lymphocytes, monocytes, histiocytes, 
polymorphonuclear cells (PMNs) and a scattering 
of eosinophils are seen; special staining is required 
to reveal the basophils. In the special case of 
intense contact-sensitivity to picric acid, subepi-
dermal abscesses of nearly pure PMNs are found 
[24]. In recent studies by Dvorak and his group 
[28,29], the elegant techniques of fixation, embed-
ding and of staining have led to a recognition of 
basophils in D-H reactions and have confirmed the 
earlier study of Per Wolf-Jurgensen [30] with the 
skin-window technique. At first, basophils were 
thought to be characteristic of Jones-Mote reac-
tions; further studies have shown that they occur 
in various numbers in all D-H reactions, but rela-
tively fewer in tuberculin test sites. Fibrin, usually 
a prominent component of D-H, occurs principally 
Vol. 67, No.1 
intervascularly in the reticular dermis, but does 
not approach the vessels or cuffs of the perivascu-
lar cells [31]. 
An elaborate and highly informative study of 
contact reactions in man has been made by Dvorak 
et al [32], who based their result on a microscopic 
study of 180 biopsies, many serial, from volunteers 
sensitized to DNCB. Basophils were observed in 
91 % of the positive reactions at their peak, fewer 
than those in sensitized guinea pigs; mast cells 
were also evident. Skin testing with microbial 
antigens had induced basophils in 61 % of the 
biopsies, less than in the guinea pig. The role of 
basophils is not known; instead of explosive de-
granulation, bits of granules appear to be released 
slowly and many granules remain intact. Now that 
guinea-pig basophils can be purified, closer studies 
may be possible [33]. 
Jones-Mote Reactions 
An evanescent period, during which D-H reac-
tions can be demonstrated, occurs 5 or 6 days after, 
for example, injection of guinea pigs with oval-
bumin in IFA. These delayed reactions are usually 
of low intensity [28,34]; suppressor B-cells are 
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FIG. 1. Contact sensitization induced by picrylated 
epithelial residues. The baseline indicates the intensity of 
reaction at 24 hr after contact tests with 1 % picryl 
chloride in corn oil were applied on days 5 or 6 following 
the intradermal injections described in the text. Grad-
ings : +, confluent, faintly pink reaction, only slightly 
thickened as palpated; + +, pale pink, moderately thick-
ened; + + +, between pale pink and pink, indurated; 
+ + + +, solid, strong pink, well indurated; + + + + +, 
bright pink, markedly indurated. The vertical dashed 
line is set arbitrarily at + + in order to exclude counting 
the few animals which may show high irritative or 
"toxicity" reactions. With each group tested, naive 
animals of same sex and weight are tested in parallel . 
Experimental animals with contact reactions rated as 
+ + + to + + + + + can be accepted without question as 
being highly sensitive. Groups A 1 and A 2 : a single 
picrylated skin extract injected alone or with alumina; 
Group B: another preparation, injected intradermally 
alone; Group C: the same preparation injected intrave-
nously as control; Group D, a third preparation, prepared 
fr?m epithelial residues of Wright's Family XIII guinea 
pIgS. 
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enhanced if cyclophosphamide (which suppresses 
B-cells) is given 3 days before sensitization [35,36]. 
Dvorak et al [28,29], using thin plastic-embedded 
sections, discovered large numbers of basophils in 
such test sites and proposed a special name, 
cu taneous basophil hypersensi ti vi ty (C BH). This 
term must be taken only in a relative sense since 
basophils appear in all sorts of D-H reactions. 
Currently, Dvorak retains CBH even for allergic 
contact hypersensitivity and believes that only 
reactivity induced by CFA is actually classic D-H. 
This extraordinary conclusion would put D-H 
apart from the bulk of delayed-type reactions, 
which would then be known as CBH. In Jones-
Mote reactions, the feeblest of the D-H reactions, 
cellular transfer is demonstrable. Furthermore, in 
all CBH reactions, the lymphocyte remains the 
controlling cell. Since cyclophosphamide acts on 
B-cells and Jones-Mote sensitizations are stronger 
when it has been used (see above) , it seems 
reasonable to grade D-H reactions on a scheme of 
intensities and to welcome basophils as cells whose 
role is under current investigation. 
Basophils also occur in relation to antibody-
induced reactions [38]. Askenase [39] sensitized 
guinea pigs with a substituted oxazolone in a 
manner that led to the appearance of circulating 
antibody, probably IgG l . When the serum of these 
animals was transferred to a recipient it gave rise 
to the same slow binding of antibody at test sites 
that I have observed and that can imitate a weak 
delayed reaction. 
ROLE OF THE SKIN IN ALLERGIC CONTACT 
DERMATITIS 
Sensitization by Simple Allergenic Chemicals 
In simple sensitization by allergenic chemicals, 
that is, without the use of adjuvant, a deposition of 
the sensitizer in sites other than the dermis usually 
fails to sensitize. Yet sensitization is possible via 
other epithelia-vagina, uterus, colon-and the 
sensitized animal will exhibit typical contact reac-
tions on the skin [26]. Since hapten sensitizes after 
it couples with carrier, which is so altered by the 
attachment of a sufficient number of haptenic 
groups per mole as to be recognized as "non-self," 
many attempts have been made to produce a 
sensitizing complex in vitro. Dinitrophenylated 
serum albumin or entire human serum proteins, 
used in conjunction with CFA, induced contact 
sensitivity only marginally; moreover, such prod-
ucts were unreactive in skin tests of persons 
sensitive to DNCB or dinitrofluorobenzene 
(DNFB). 
In place of serum proteins, soluble proteins 
extracted directly from guinea-pig skin and cou-
pled with picryl chloride (PC1) and injected in IF A 
gave a glimmer of sensitization [40,41]. (Some 
proteins are found only in the dermis and certain 
others are shared by other organs.) Finally, Chase 
and Kawata [42] showed that homologous epithe-
lial scrapings are the proper carrier for hapten 
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coupling. These were defatted, thoroughly ex-
tracted, and subdivided by sonication so that they 
could be injected into the skin. Such material was 
coupled with PCl or DNFB, and excessive un-
reacted hapten was removed before it was used as a 
direct sensitizer (Fig. 1). Five simultaneous intra-
dermal injections of 0.05 ml containing picrylated 
skin particles (10-400 f..Lg total dose) were made in a 
circular pattern on one shoulder. When a contact 
test was applied 5 days later and read the following 
day, contact sensitivity was highly developed. The 
elapsed time between injection and contact testing 
was less than when PCl is injected intradermally 
since the free hapten requires time to couple. 
Moreover, the reactions were more brilliant, a 
point to be mentioned later. Dinitrophenylated 
skin particles bring a reasonable degree of contac-
tant sensitivity to DNFB or DNCB to half the 
injected animals, sufficient to confirm the princi-
ple. This experiment shows that intradermally 
deposited, insoluble skin particles provide a com-
plex that sensitizes without requiring the animal to 
encounter free hapten. The bulk of the injected 
material must stay in the skin since marked flaring 
occurs at the intradermal injection sites around 
day 4 or 5, but undoubtedly some of it is transported 
elsewhere . 
The Role of Lymphatics 
When the sensitizer is placed upon an isolated 
island of skin [43] or a stalk of isolated tissue [44], 
sensitization occurs only if the lymphatics are 
patent. Conversely, when foreign tissue is grafted 
to the alymphatic cheek pouch of the hamster, 
which is called a "privileged site," delayed sensi-
tivity does not occur [21]. 
The lymphatic channel draining the cutaneous 
site of deposited allergen was long thought to serve 
as a passage for allergen-or antigen from a skin 
homograft-to the draining nodes, where the ac-
tual sensitizing sequence took place [45,46]. But 
this is evidently not so for sensitization with aller-
genic chemicals of the DNCB or substituted oxazo-
lone type except where CFA has bee-n used. Sen-
sization occurs in the skin at the site where hapten 
becomes bound to the structural tissue; lymph 
cells arrive at that "training field" by traversing the 
walls of blood vessels and, once there, somehow 
acquire the ability to recognize the hapten-tissue 
complex. The patent lymphatic serves rather as a 
path whereby lymphocytes escape to the nodes, 
where the cells divide and clonalize and are ready to 
respond when the same hapten-tissue complex is 
formed anew by a subsequent contact test. Evi-
dence for this theory comes from the work of Egon 
Macher in my laboratory, who used 14C-labeled 
PCl and DNCB precisely injected in 0.01 ml 
amount into the ear of guinea pigs, and avoided us-
ing large dosages that would provide extrasensitiz-
ing amounts. Ear excision showed that free hapten 
rapidly left the injected site through the walls of 
blood vessels, not through the lymphatics. When 
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99% had drained away and therefore had already 
become "available" to the animal, excision of the 
ear with its small residuum of bound hapten still 
blocked sensitization [17,47,48]. Sensitization via 
radiolabeled urushiol may be an exception [49], but 
we think not. Evidently urushiol, the active princi-
ple of poison ivy, becomes altered very slowly in its 
catechol groups and is found widespread through 
the body. The fact, however, does not preclude the 
theory of "peripheral sensitization," which is the 
term proposed by Medawar [50] to suggest that 
homograft rejection is the result of attack by host 
lymphocytes which have acquired their recognition 
of "non-self' within the very graft. A probable 
exception to the theory of peripheral sensitization 
is the induction of sensitivity with CFA, where (it 
may be surmised) local sites around deposited 
mycobacteria, the chemistry of which induces 
cellular proliferation, serve as training fields [17 J. 
In skin homografting, where patency of the 
lymphatic pathway from the graft is necessary for 
its rejection, and obliteration of the pathway 
prolongs survival, it was again concluded that the 
patent lymphatic allows the "trained" lymphocytes 
to escape [51]. 
As a final step, Macher and Sommer attempted 
to "train" lymphocytes to recognize antigen in 
vitro [52]. Eventually, Polak and Macher [53 J 
reported that some measure of success seemed 
attainable; further discussion will be found under 
The Unresponsive State. 
Sensitization with Dinitrophenylated (DNP) 
Amino Acids and Simple DNP Complexes 
Reports that contact sensitivity will arise by 
simple intradermal injections of DNP-amino acids 
in the absence of adjuvants will be mentioned 
briefly. An excellent study with 35 such com-
pounds [54] reports that 10 were regularly immu-
nogenic, and 15 were variably immunogenic, i.e., 
were negative when purchased from source No. 1 
and immunogenic from source No.2. Such source-
dependent results are interpreted as dependent 
upon contamination with some immunogenic im-
purity possessing DNP specificity and being car-
ried along through the commercial processing 
steps. Of the 10 immunogenic compounds, di-
DNP-L-histidine received most study: the authors 
concluded that a "transconjugation" phenomenon 
occurs with the positive compounds, a switch of the 
DNP group directly from the amino acid carrier to 
adjacent proteins, and evidence is offered in sup-
port. The in vivo fate of the most-quoted D-H 
immunogen, p-azobenzene arsonate-tyrosine, is 
apparently not elucidated. 
ROLE OF THE HAPTEN CARRIER IN DETERMINING 
THE SPECIFICITY OF DELA YED-TYPE 
HYPERSENSITIVITY 
When haptens are attached in vitro to a series of 
unrelated proteins and sensitization is achieved 
with one of these compounds via CFA, subsequent 
testing, which requires intradermal injections, 
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shows that reactivity is confined to the particular 
complex used to sensitize; the other carriers, bear-
ing the same hapten, cause no reactions [55]. This 
finding led to the dictum that specificity in D-H is 
determined by the entire complex, but that IgG 1 
and IgG 2 antibodies to the same complex cross-
react with all the complexes by virtue of the 
common hapten group. The principle was con-
firmed by David et al who used carriers of widely 
different provenance to produce MIF in vitro [56]. 
I gave an example above in which different 
carrier structures within an animal may be en-
gaged depending upon the route chosen for sensi-
tizing. Another example is worth citing. Intrader-
mal (i.d.) injection of picric acid-insolubilized 
protein leads to a D-H reaction that is confined to 
i.d. testing with picric acid; only the i.d. sensitivity 
is transferrable with cells, and recipients do not 
react to contact testing with picric acid [25]. But 
in sensitization to picric acid by the split-adju-
vant technique [24], in which both i.d. and contact 
routes are utilized, cellular transfer effects a sensi-
tivity which is expressed in both i.d. and contact 
tests. The finding again suggests that the carriers 
utilized in i.d. injection and in application to the 
epidermis are sufficiently different to modify the 
specificity observed. 
CELLS AND DELAYED HYPERSENSITIVITY 
The first clear indication of the role of lympho-
cytes in delayed hypersensitivity came in 1942 for 
allergic contact dermatitis of the guinea pig [3] and 
in 1945 for tuberculin hypersensitivity (4] when 
cellular transfer was demonstrated in outbred 
guinea pigs. Systemic reactions to tuberculin after 
transfer were first reported by Kirchheimer and 
Weiser in 1947 [57]. The highly erythematous color 
of contact reactions is a vascular "overlay," which 
disappears when the animal is exsanguinated to 
reveal the palpable cellularity within the dermis 
and epidermis. The mouse and rat also develop 
delayed reactions, but they do not exhibit the 
vascular component. 
Cellular Transfer 
Cellular transfer of delayed hypersensitivity has 
become routine in animal experiments. Purists (I 
am not among them) reserve the term "adoptive 
immunity" for cellular transfers made between 
isologous or near-isologous stocks in which rejec-
tion phenomena are hardly evident. But for many 
purposes, the rejection of cells transferred between 
outbred guinea pigs is desirable. With contact 
sensitivity, reactions occur at or before 19 hr if the 
contact test was given 3 hr before the cells were 
injected. WesslEm showed that transfer between 
rabbits also occurred with thoracic duct cells and 
thus narrowed the cell-type involved [58]. 
By cellular transfer between monkeys, Hensley, 
Fink, and Barboriak [59] have investigated the 
delayed hypersensitivity aspects of allergic pneu-
monitis. The cell sources can be peripheral blood, 
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peritoneal exudate cells, and lymphoid cells from 
nodes or spleens. Peritoneal exudate cells appear to 
be almost totally devoid of B-cells since immuno-
globulin is not synthesized by them [22]. 
Emphasis on the role of cells in "transplantation 
immunity" led to the early introduction of the 
unfortunate term CMI (cell-mediated immunity), 
which should be replaced by CMH (cell-mediated 
hypersensitivity, the actual underlying state) . I 
reserve the term CMI only for cases of immunity 
induced by transferred cells to infectious agents, 
such as virulent Listeria monocytogenes [60,61]. 
This relation of CMI to resistance to infection has 
been studied under the WHO [62]. 
Correlates of Delayed Hypersensitivity in Vitro 
It was natural to try to determine whether cells 
of sensitive animals respond in vitro to antigen, 
but this hypothesis could not be tested directly 
with simple chemical allergens. Delayed hypersen-
sitivity to hapten-protein complexes in CFA and 
tuberculin hypersensitivity are amenable to study. 
George and Vaughan [63] packed peritoneal exu-
date cells within a capillary tube and exposed the 
superficial layer of cells to antigen in a small 
chamber. The antigen did indeed restrain an 
outgrowth of the monocytes. The technique was 
picked up by David and co-workers [64] and later 
by Bloom. David et al used the hapten-carrier 
system and easily confirmed the findings of Gell 
and Benacerraf about carrier specificity [64]; 
Bloom and Bennett [65] used the tuberculin sys-
tem. Working separately, each soon found that the 
inhibition of migration was due to a soluble agent, 
which is not preformed within the cells [65-68]. 
Only the lymphocytes in the system had to be 
derived from sensitized animals; macrophages 
from a normal animal would serve. Thus an 
examination of culture supernatants containing 
lymphocyte metabolites was started. The soluble 
material was called macrophage inhibition factor 
(MIF). With application of different techniques by 
various workers, a large variety of "factors" has 
now been found, collectively termed "lympho-
kines" by Dudley Dumonde. Crude "MIF" is all of 
these. Actual MIF is only one of these. There are 
separate chemotactic factors for PMNs, mono-
cytes, and, if antigen is present, for eosinophils. 
Factors that inhibit the proliferation of the cloning 
of HeLa cells are reported. There is also an 
inhibitor of DNA synthesis, a toxin for mouse 
L-cells, and a blastogenic factor. About 5 of a long 
list are identifiably separate factors . The media-
tors bind to the target cells; the binding site for 
MIF on macrophages possesses a terminal glucose 
residue. If culture filtrates are highly concentrated 
and injected intradermally into a naive guinea 
pig, a faintly pink swelling appears in about 4 hr 
and soon recedes. It has been bravely ,termed 
"instant hypersensitivity." 
Since guinea-pig monocytes respond to culture 
filtrates of human cells incubated with antigen, an 
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"indirect" MIF test is often used to study human 
lymphocytes. Still other techniques for performing 
the MIF test have been developed, including those 
which, in place of capillary tubes, use an assay 
of spreading on agar or on carboxymethyl cellu-
lose "gum." 
Another powerful tool for studying D-H in vitro 
is to expose cells to antigen in tissue culture for 
about 5 days. Blast forms, growing rapidly, can be 
seen microscopically or assessed by incorporation 
of a terminal pulse of [3H ]thymidine [69]. Ade-
quate controls are needed to properly assess the 
blastogenic effects. 
In vitro tests with cells taken from contactant 
type D-H have posed a problem because we do not 
have a proper carrier for haptens. Tests for MIF 
production have failed even though a wide variety 
of DNP-products, including DNP-guinea pig mi-
crosomes, has been tried. But recently blast trans-
formation has been achieved by Levis [70,71], who 
coupled DNCB to human erythrocytes by means 
of dimethylsulfoxide (DMSO). In DNCB-sensi-
tized rabbits, erythrocyte carriers similarly coup-
pled, whether in rabbit, rat, or guinea pig, have 
stimulated cells to blastogenesis . 
Lymphocyte Types 
Since T-lymphocytes and B-Iymphocytes (thy-
mus-derived, bone marrow-derived) have been rec-
ognized as separate types, numerous studies have 
shown interaction between the two. The B-Iym-
phocyte, which is capable of synthesizing specific 
antibody, can restrain T -cells, while T -cells can 
function as "helper" cells for B-cells in this synthe-
sis; T -cells can also restrain B-cells. Obviously 
there are several subpopulations of T -cells. One or 
more of these sub populations represent the effector 
of D-H. For certain studies, mice with visible 
"theta" markers on their T -cells, as well as the 
"nude mouse," which is genetically athymic, have 
proved useful. 
The lymphocyte types-B, T, and the newly 
discovered Null cells-must be separated for defin-
itive studies. The properties of these three types 
are given in Table II. None of them can phagocy-
tize; B-cells carry surface immunoglobulins; T-
cells rosette directly with sheep erythrocytes, but 
B-cells do so only when antibody and complement 
are present (erythrocyte-antibody-complement 
(EAC) rosettes). All three types respond to mito-
gens of some class. The newly discovered fact that 
B-cells produce much more MIF than T -cells has 
discouraged many workers who no longer believe 
that MIF production is a useful correlate of D-H. 
But in my experience [22], tests with the peritoneal 
exudate cells of guinea pigs are reliable since 
B-cells are not likely to be present. Alternatively, 
B-cells can be removed on an immunoadsorbent 
column bearing rabbit anti-IgG. Cellular prolifera-
tion is not necessary for MIF production by B-cells 
which continues when the cells are restrained by 
bromouridine (BUdR) with light. Properties that 
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TABLE II. Properties of lymphocyte typesa 
Thymus-derived (T) cells, bone-marrow-derived (B) cells, and the newly recognized class of "Null" lymphocytes 
are differentiable as summarized in the text. Abbreviations: Surface Ig, immunoglobulin bound to and forming part 
of the cell surface; E, (sheep) erythrocytes; EAC, (sheep) erythrocytes plus antisheep antibody plus complement; 
PHA, phytohemagglutinin; Con-A, concavalin A; Hu Ig, human immunoglobulin; MIF, macrophage inhibiting fac-
tor; Ag, antigen; MLC, mixed lymphocyte reaction (see text). 
Antibody-dependent cell-mediated cytotoxicity refers to the ability of lymphocytes to lyse fresh chicken red cells 
which have been coated with Hu Ig or rabbit Ig or rabbit anti-Hu Ig at a killer-to-target cell ratio of 15:1. 
T 
Latex ingestion 0 
Surface Ig 0 
E-rosettes + 
EA C -rosettes 0 
Nylon adherence 0 
PHA/ Con -A/ pokeweed +++ 
Blasts via mit ogen N o Ig 
Hu Ig-chick RBC b 0 
MIF via Ag + 
Interferon + 
Chemotactic fa ctor + 
[3H ]Thymidine + Ag + 
























One-way MLC + (killers generated) o 
o 
o 
a Data rearranged from Chess et al [7 2 ] 
b " Antibody-dependent cell-mediated cytotoxicity (ADCC) " 
are unique to T -cells are direct rosetting with sheep 
erythrocytes , thymidine incorporation by sensi-
tized cells in the presence of antigen , and the 
ability to become aggressive in one-way mixed 
lymphocyte cultures (MLC). (The target cells are 
restrained by actinomycin or mitomycin C: the 
lymphocytes under test develop killer cells , which 
can later be harvested and w:: ed to speedily attack 
other cells of the target provenance.) T -cells can-
not lyse chicken erythrocytes coated with specific 
immunoglobulin in contrast to B-cells and Null 
cells. The mitogen factor which is ;:l.ctive on B-cells 
appears only in the media of cultured T -cells. 
Separation of the three types of lymphocytes 
depends upon the properties shown in the upper 
section of Table II. B-cells are first removed on a 
solid immunoadsorbent bearing Fab fragments 
prepared from antihuman immunoglobulin (Ig) . 
Later they are harvested by displacement from the 
column with human Ig. The other cells are re-
covered from the wash-through, which is divided 
into two portions. One is processed for T-cells by 
EAC rosetting of Null cells and any remaining 
B-cells, the rosettes are removed on a density 
gradient of Hypaque-Ficoll, and the contaminat-
ing monocytes are trapped by adherence to cotton 
wool. The other portion is processed in reverse to 
obtain the Null cells: E-rosettes are removed on 
the density gradient and the monocytes on cotton 
wool [72]. 
Gell and Godfrey [73] extracted from the total 
T-cells those which are specifically committed to 
function in DNP-contact tests by first binding the 
cells to DNP-bearing polyacrylamide columns and 
then discharging them upon passage of DNP-
amino acids. These committed cells appear to 
differ from the E-rosetting cells. 
Macrophage Response to Lymphokines 
Confined within chambers and exposed to in-
creasing concentrations of lymphocyte metabo-
lites, macrophages are paralyzed. But in vivo, 
antigen introduced into a sensitized animal pro-
duces dramatic changes : the macrophages enlarge 
greatly, metabolize with new energy, spread read-
ily on glass, and acquire a marked propensity for 
phagocytosis. Such cells (Figs. 2, 3), which are 
termed "angry macrophages," have been studied 
by Blanden, Lefford, and Mackaness [74] and by 
others . Anyone of several specific D-H systems 
leads to excitation, but antigen must be provided 
periodically to sustain the effect. Since the "angry 
macrophage" has a catholic taste for foreign invad-
ing bacteria of any sort, the animal can escape 
death from microbes entirely unrelated to its 
immunologic sensitization [60-62]. 
THE UNRESPONSIVE STATE (TOLERANCE) 
By 1946, it was known that feeding a sensitizing 
chemical to a naive animal would abort or mark-
edly reduce the development of D-H if an attempt 
was later made to sensitize with the same com-
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FIG. 2. The effect on macrophages of sensitization and restimulation . Peritoneal cells from mice sensitized with 1 x 
104 living BCG cells 25 days before. The cells from such a mouse (left pane!) were_ photographed after 3 hr of incubation. 
Few of the cells have spread; most remain rounded up . Cells in the right panel are from a mouse reinjected 48 hr before 
with 1 x 107 living BCG; the picture was taken after only 15 min to show the rapid spread on glass and the prominent 
mitochondria. 
FIG . 3. Left panel: Peritoneal cells from a normal mouse in tissue culture for 24 hr, a time sufficient for spreading. 
l ight panel: Cells from a BCG-infected mouse after reinjection, cultured similarly ; about two-thirds of one 
'nacrophage occupies the center. Compared with the left-hand panel, there is an increased tendency to spread on glass; 
nitochondria are filamentous ; phase-dense lysosomes are numerous; the phase-lucent vesicles indicate active 
,)inocytosis. (After Blanden, Lefford, and Mackaness [74]) 
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pound [75 J. The unresponsiveness was shown to be 
specific for the compound fed; moreover, the 
synthesis of IgG l antibody, which the active sensi-
tizing treatment was expected to initiate, was 
markedly depressed, i.e., anaphylaxis did not 
occur after the intravenous injection of hapten-
protein complex. If more stringent sensitizing pro-
cedures were used, hapten-specific antibody did 
become synthesized, but the sensitivity to contact 
testing was elevated only slightly [76,77 J. The 
system, highly effective in guinea pigs with hap-
tens which are soluble in triglyceride oil, failed in 
man even when aqueous dilutions of tincture of 
Krameria were fed repeatedly and a sequence of 
patch tests to induce sensitivity was applied [78]. 
The subject was not pursued in man for some 
years. 
Pomeranz and Norman [79,80] resumed the 
study with picryl chloride in guinea pigs. They 
used a single large intragastric feeding and docu-
mented the time of onset of tolerance. Lowney then 
induced tolerance in guinea pigs with p-
nitrosodimethylaniline (NDMA) and later cau-
tiously experimented with 97 human volunteers 
with DNCB [81]. After 7 patterns of treatment, 
Lowney concluded that unresponsiveness arises 
from repeatedly applying either 50 J.Lg DNCB over 
20 to 40 contact sites at one time (6 out of 16 
subjects became solidly tolerant) or larger doses of 
DNCB on the buccal mucosa (Fig . 4) . The latter 
method shows promise. 
In animal models, however, a greater unrespon-
siveness to DNCB was developed by Frey, deWeck, 
and Geleick [82 ,83] who used a very large intrave-




TOPICAL SENSITIZATION .. 
FOLLOWING DNCB ON BUCCAL MUCOSA 
750~ ea . 2d wk , 55"10 I 
1-4x; weekly • , 
• • ; 9-IOx • • : • " • • ?? 
300~ weekly 55"10 
5-6 x • 
• , 
• 
• • • • ? 
300~ea. 2d wk, 58"10 
8-IOx • J 
• • J 
• • J • • • • • • • 
21"10 I Positive I 
I • • Controls •• • • • • I •• • • 
• • I •• • • : • • • :: 
· 
: : • • • • • 
N.S. 50 + 50t - - - - - - - - - - - - - - - - -+ O.4t 
Maximal Reactivit y 
* 150t x 4 aver 2 .5 cm weekly, . up to 8 x 
FIG. 4. Each closed circle represents a volunteer. After 
several procedures, all subjects were given the sensitizing 
course listed. Final titrations of reactivity are shown; the 
percentage of persons remaining in the program (some 
withdrew) are shown in the left margin. Persons rated as 
negative or trivial reactors are located on the left side of 
the dashed line, being either nonsensitive or minimally 
reactive to test concentrations greater than 50 Jlg. The 
sensitizing procedure failed to sensitize 21 % of the control 
group, but this percentage was raised to 55-58% in the 
experimental groups. (Rearranged from data of E. M . 
Lowney, J Allergy Clin Immunol 48: 28, 1971) 
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ble substance of low toxicity. This method also 
served to desensitize a sensitized animal provided 
an intradermal injection of DNCB was given 
within 12 to 24 hr afterwards. 
Whatever the procedure, tolerance can be built 
up in adult animals only if the modes of applica-
tion avoid early stimulation of the antibody-form-
ing apparatus. 'When cyclophosphamide, which is 
known to restrain B-cells, was used to cover guinea 
pigs during the administration of antigenic hap-
ten-protein complexes, Salvin and Smith [84J 
established tolerance. Tolerance involves a re-
straint of some populations of T-cells which ex-
tends to normal cells newly introduced into a 
tolerant animal. Parabiosis of a normal and toler-
ant guinea pig for 10 days rendered it completely 
unresponsive [85 J. 
Animals thus rendered tolerant are widely used 
in special studies. In the experiments of Polak and 
Macher [53], lymphocytes exposed in vitro to small 
concentrations of DNCB had to be injected living 
into recipients even though the complete removal 
of the free chemical could not be assured. Accord-
ingly, the recipients were made deeply tolerant to 
this allergenic chemical by a previous intravenous 
injection of DNP-sulfonate; therefore, the effects 
could not be ascribed to an active sensitization. 
TRANSFER FACTOR 
Transfer factor (TF) is an immunologic mys-
tery, but so was IgE to immunologists once. In 
some fashion, this low-molecular-weight material 
exerts control over lymphocytes. TF was discov-
ered around 1954 and has been studied largely by 
H. S. Lawrence and his colleagues; their work over 
the years is recounted in [86]. In the earlier years, a 
crude material was secured from peripheral lym-
phocytes of sensitized human beings either by (a) 
freezing and thawing, followed by digestion of 
nuclear material by DNase-plus-MgSO. , (b) incu-
bating cells in a relevant antigen such as tuber-
culin, or (c) shaking with glass beads. The dialyza-
ble nature of TF was discovered in the early 1960s, 
and TF D is now universally used, since the trans-
plantation antigens, which can sensitize the recipi-
ent, remain in the retentate. Dialysates are now 
usually lyophilized. 
TF D can be processed on Sephadex G25 and G 10 
and on polyacrylamide to remove an inhibitor of 
unknown type and to permit search for the active 
fraction. The molecular weight of the dialyzing 
material is estimated as less than 4000 daltons. 
One "unit" is bas,-;! .... r X 108 lymphocytes in the 
starting material, or, in England, on 1 x 109 
lymphocytes. There is as yet no unit of potency, 
which varies directly with the hypersensitivity of 
the donor. Because of the salts present, the weight 
of the material recovered in the dialysate is not 
known. 
Since adult human beings have developed vari-
ous types of D-H to infectious agents [88], all 
preparations of TF D possess an assortment of TFs. 
Selective TF oS are made from donors highly sensi-
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tive to the property that is to be transferred. (An 
extensive bibliography is given in [86] and recent 
studies in [89-91 ].) 
Injection of TF 0 from a donor highly sensitive to 
tuberculin will convert a pretested, normal recipi-
ent to tuberculin sensitivity, a state which can be 
detected shortly and apparently matures within 4 
or 5 days and which leaves the recipient sensitive 
for many months or years. Pretesting and post-
testing the recipient with a battery of recall anti-
gens discloses other types of D-H which may be 
contained in the preparation used. TF 0, then, 
provides some sort of immunologic fillip. But TF 
exists in man only for microbial, fungal , and viral 
agents; it has never been reported on the lympho-
cytes of patients with allergic contact dermatitis. 
This is not surprising because cellular transfer of 
contact hypersensitivity is much more difficult to 
achieve in man than in the guinea pig. Despite its 
very small size and some conf1icting data, TF 0 
generally conveys specific information to the recip-
ient. A most important recent finding by Ascher et 
al [92] suggests new ways to evaluate TFo in vitro . 
Rather than conducting dialysis into water and 
lyophilizing, the lysate is now dialyzed directly 
into a small volume of Medium 199, which is used 
directly. This slight technical alteration yields a 
TFoM which can instruct naive human lympho-
cytes to react to specific antigen and to incorporate 
thymidine. The blastogenesis may involve a 2-
stage effect, such as an initial triggering by TF OM 
that provokes cellular synthesis of a nondialyzable 
factor which then leads to blastogenesis . Cultured 
lymphoblastoid cells from a nonsensitive human 
donor are reported to respond to TF 0 by synthe-
sizing TF through the B-cells in the preparation 
[90 ]. 
In recent years , the "re-arming" of patients with 
D-H immunodeficiencies by me.ans of TF 0 has 
been reported to be beneficiaL Since such patients 
do not retain the newly acquired hypersensitivity 
the same way a normal recipient does , repeated 
injections are necessary. In pilot studies, TF 0 from 
highly chosen donors or from donors possessing 
other specificities of TF oS has been given to about 
225 patients in many disease categories such as 
Wiskott-Aldrich syndrome , chronic candidiasis , 
acute malignant measles , congenital rubella , acute 
rheumatoid arthritis , osteogenic sarcoma, acute 
leukemia, leprosy, coccidioidomycosis , multiple 
sclerosis , and subacute sclerosing panencephalitis. 
Many patients acquire, at least temporarily , skin 
reactivity to test antigens and in vitro antigen-
induced blastogenesis. Up to 30% or so patients 
may show some degree of clinical improvement, 
sometimes for a few months. Such improvement, 
when it comes, is said to be evident after the initial 
injections. Double-blind studies are needed to 
evaluate the actual therapeutic effect of TF 0 and 
::'0 determine whether specificity (TF 0+) or only 
"broad spectrum" effects (TFo(- )) are necessary. 
Such studies are being planned for leprosy and for 
:~occidioidomycosis . 
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If the benefits which derive from the use of 
TF o 1- 1) are tested by sequential skin tests with a 
battery of recall antigens, they could be attributed 
to the provoking of "angry macrophages" by re-
armed, antigen-stimulated lymphocytes, which 
thereafter become nonselective in the foreign ele-
ments which they attack. 
THE FUTURE? 
Cell biologists and immunologists will surely 
lead in classifying the subpopulations of B- and 
T-cells for which we have only indirect evidence so 
far. Much new data can be derived from a study of 
the interactions between the various cell types, 
including basophils and eosinophils. But within 
the sensitized individual, each testing will initiate 
the same complex, intertwined events. Surely the 
scanning electron microscope , which utilizes 
thicker sections , can be expected to show how 
intimately the invading cells are packed against 
one another and against the basal epidermal cells 
in which spongiosis occurs. 
\Ve know that ultimately the package oflympho-
kines will be broken open to reveal the actual 
number and relative importance of the compo-
nents and that probably the metabolites of macro-
phages and basophils can be examined as welL 
The biologic problem of TF, which has been 
subverted by the lurch to therapeutic use in 
patients , deserves a much better experimental 
design. Is it really narrowly specific, and if so , how 
is this property possible in so small a molecule? 
Can it be secured in weighable amounts , free from 
magnesium sulfate in the dialysate? Can its activ-
ity be standardized? Does it arise from macro-
phages or B-cells and indirectly activate the T-
cells from which it is harvested? Is it adsorbed by 
purified T -cells? Is there a TF 0 which converts 
normal human subjects into contact-sensitive pa-
tients? Will TF 0 function if recipients are injected 
with test antigen 6 months before the injection of 
TF 0 and are not tested until 3 more months have 
elapsed? In other words , does antigen playa role 
when given shortly before or after TF? 
So far no animal model has been found in which 
to study TF under controlled experimental condi-
tions. Even if animals have now and then shown 
some evidence of TF 0 , we still need a system that 
yields reproducible results and material of good 
activity before we can replace man as the primary 
test subject. Further work may reveal this sorely 
needed model. 
Studies in physiology are needed to provide us 
with a better understanding of the events begun by 
immunologic triggering. Why, for example, does a 
sensitized guinea pig respond so poorly on the day 
of or on the day after the drawing of moderate 
amounts of blood? The proportion of T-cells with-
drawn by the bleeding must be trivial compared 
with the reserves left in the blood, nodes, and 
spleen. We cannot escape the conclusion that we 
still have much to learn and that we will do so only 
through new modes of experimentation. 
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